The Schools of Pharmacy & Pharmaceutical Sciences and Biochemistry & Immunology, Trinity College Dublin in conjunction with Biruni University, Istanbul, Turkey, invite you to attend the international “Computer-Aided Drug Design (CADD) Symposium and Workshop – Linking Design, Biology, Chemistry and Medicine” in Trinity College Dublin on May 3rd & 4th 2018.
The focus of the symposium is to bring together academia and industry with an interest in the validation of novel biomolecule targets to treat disease with an unmet clinical need and in applying computational technologies towards the discovery and development of potential small molecule drugs. The main goal of the symposium is to forge interdisciplinary and trans-sectoral connections to foster novel drug discovery projects.
With this goal in mind we have a wide target audience spanning the fields of chemistry, biology, medicine, pharmacy, computational design and beyond. We wish to create an environment where large/ SME pharmaceutical and biotechnology companies, and academics can more readily appreciate how each sector contributes to drug discovery research and encourage closer collaboration.
Two ERC awardees, the Head of Computational Chemistry in Cardiovascular, Renal and Metabolic diseases at AstraZeneca and staff from three Irish pharma/biotech SMEs (Galactica Biotech, HiTech Health and Nuritas) are amongst the exciting line-up of speakers.
While the scientific meeting will be guided by experts in the field of CADD, talks will be framed towards illustrating how chemistry – biology – design can synergistically interact with each other to bridge into the realm of medicine. We encourage early stage researchers who are not working on CADD projects to submit speaker/poster abstracts so that they can present their projects and stimulate discussion with other attendees. A Panel Session is scheduled where we want the audience to guide the topics for discussion towards answering the question “how can computational drug design help me?”
Drs. Abdulilah Ece, Tatjana Braun and Darren Fayne, with support from Schrödinger LLC, will run an international-standard software workshop on the second day which will provide attendees with hands-on experience of CADD methodologies. Please note that there is a hard cap of 50 attendees at the workshop and slots will be allocated as paid registrations are received.
CADD approaches are widely used in academia and by SMEs, pharmaceutical and biotechnology companies. A selection of successful applications of CADD includes the FDA approval of Captopril, Dorzolamide, Saquinavir, Zanamivir, Oseltamivir and Aliskiren. An aim of this symposium is to discover how these technologies can help with your project.
We look forward to welcoming you to Trinity College Dublin, Ireland!